Lactobacillus Gasseri

The mix of bacteria living in your vagina has a measurable effect on how easily you get pregnant, how your body handles HPV (human papillomavirus), and whether you keep getting recurrent infections. One of the species researchers use to gauge whether that ecosystem is in a healthy state is Lactobacillus gasseri, often abbreviated as L. gasseri.

This swab does not diagnose a specific disease. It tells you whether one of the main Lactobacillus species of the vagina is present and abundant, which is a signal that your microbiome is leaning toward the patterns linked to lower bacterial vaginosis risk, faster HPV clearance, and higher chances of conception.

What This Test Actually Measures

L. gasseri (Lactobacillus gasseri) is a lactic acid-producing bacterium. It is not a hormone, protein, or metabolite. The swab quantifies how much of this specific bacterium is colonizing the vaginal walls at the time of collection. Researchers group vaginal microbiomes into community state types (CSTs). The four dominant vaginal Lactobacillus species are L. crispatus (CST I), L. gasseri (CST II), L. iners (CST III), and L. jensenii (CST V). L. crispatus, L. gasseri, and L. jensenii are generally considered protective, while L. iners frequently occurs in transitional or dysbiotic states and is linked to progression to bacterial vaginosis.

The reason this species matters is that it produces lactic acid, which keeps vaginal pH low (acidic) and suppresses the anaerobic bacteria (those that grow without oxygen) that cause bacterial vaginosis. Some strains of L. gasseri can also produce hydrogen peroxide in lab conditions, but recent research has questioned whether hydrogen peroxide plays a meaningful antimicrobial role inside the body, with lactic acid now considered the primary protective factor. When L. gasseri and its sister species (L. crispatus, L. jensenii) are abundant, the community is generally stable and resistant to overgrowth of pathogens.

Fertility and Time to Pregnancy

One of the more striking findings about L. gasseri comes from a pregnancy-planning cohort of 478 Chinese women. Women in the highest quarter of pre-pregnancy L. gasseri abundance were about 71% more likely to become pregnant in a given month compared to those in the lowest quarter (fecundability ratio 1.71). A microbiome type defined by low L. gasseri and low L. crispatus together was associated with substantially lower fecundability than a Lactobacillus-rich pattern.

If you are trying to conceive and finding it harder than expected, this is one of the microbiome signals with direct human data tying its abundance to how quickly conception happens. The evidence is not unanimous: a separate prospective study of 458 Kenyan women found no association between cultivable vaginal Lactobacillus and fecundability, though the authors noted the relationship may be species-specific.

HPV Clearance and Cervical Health

A small longitudinal study of 32 women tracked vaginal microbiomes alongside HPV detection over time. Women whose microbiome was dominated by L. gasseri had the fastest clearance of detectable HPV compared to other community types, though the confidence interval was wide and reflects substantial uncertainty. By contrast, microbiomes low in Lactobacillus and high in Atopobium showed the slowest clearance.

In a much larger dataset of 15,607 cervicovaginal samples analyzed by qPCR, L. gasseri was enriched in samples that were negative for bacterial vaginosis and had normal cytology results. After successful treatment of high-grade cervical lesions (CIN3, a precancerous change), women who recovered showed increased Lactobacillus species, especially L. gasseri, suggesting it tracks with cervical recovery.

Pregnancy and Preterm Birth Risk

In a study of about 1,000 Australian women in mid-pregnancy, those who went on to deliver at term had higher L. gasseri DNA in their vaginal swabs than those who later had spontaneous preterm birth. Low L. gasseri combined with higher Gardnerella and Ureaplasma marked higher risk of spontaneous preterm birth. A systematic review and meta-analysis also reported L. gasseri to be negatively associated with preterm birth risk. The evidence is not entirely consistent, however: at least one Chinese study found that L. paragasseri/gasseri was positively associated with spontaneous preterm birth, particularly in late second to third trimester.

A separate study found that pregnant women with COVID-19 showed reduced Lactobacillus species including L. gasseri, consistent with infection-driven dysbiosis (an imbalance in the bacterial community). While preterm birth risk is driven by many factors, the vaginal microbiome composition in pregnancy is one signal that can be checked.

Bacterial Vaginosis and Recurrent Vaginitis

Bacterial vaginosis (BV) is defined by depletion of Lactobacillus species (including L. gasseri) and overgrowth of anaerobes like Gardnerella, Atopobium, Prevotella, and Megasphaera. If your swab shows low L. gasseri alongside high abundance of these anaerobes, you are in a dysbiotic state even if you have no symptoms yet.

After metronidazole treatment for BV, the main shift is loss of BV-associated bacteria rather than a large rise in L. gasseri itself. The reduction in genital inflammation comes mostly from removing the harmful bacteria, not from replenishing the protective ones. Standard metronidazole treatment does typically restore Lactobacillus species to relative dominance in proportional terms, but the absolute rise in L. gasseri is modest. This is why probiotic strategies (oral or vaginal) are increasingly being studied to actively restore Lactobacillus after treatment.

Why a Single Reading Is Not Enough

The vaginal microbiome shifts with menstrual cycle phase, sexual activity, antibiotic use, hormonal contraception, pregnancy, and menopause. A single swab tells you what your community looks like that day, but it cannot tell you whether your microbiome is stable or in flux. Studies that took repeated sequential swabs from the same person at the same visit found strong short-term reproducibility of microbial profiles. But across weeks and months, the picture can change.

If you are using this test to track an intervention (a probiotic, a course of antibiotics, a lifestyle change), it is reasonable to get a baseline first and retest a couple of months later, once the community has had time to settle. Specific retesting intervals are not backed by formal guidelines and should be discussed with your clinician based on your situation, whether that is trying to conceive, managing recurrent BV, or general screening.

When Results Can Be Misleading

• Recent antibiotic use: any systemic or vaginal antibiotic in the prior weeks can suppress your normal Lactobacillus populations, including L. gasseri. Wait at least 2 to 4 weeks after finishing antibiotics before testing.
• Menstrual phase and recent intercourse: blood, semen, and lubricants in the sample can shift the apparent bacterial profile. Collect the swab outside of menses and avoid intercourse for 24 to 48 hours before sampling.
• Recent douching or vaginal products: these strip and remix the local flora. Avoid douches, vaginal washes, spermicides, and intravaginal medications for at least 48 to 72 hours before the test.
• Pregnancy and hormonal contraception: higher estrogen states favor Lactobacillus, while low-estrogen states (menopause, some contraceptives) shift the community. Your reading should be interpreted in the context of your hormonal status, not against a single universal target.

What to Do With an Unexpected Result

If your L. gasseri level is low and your swab shows high anaerobes, the next move is to ask whether you have symptoms (discharge, odor, irritation) and whether you should be tested for BV with a quantitative qPCR panel that measures Gardnerella, Atopobium, Megasphaera, and other key bacteria. A gynecologist can interpret whether antibiotic treatment, vaginal probiotics, or watchful waiting is appropriate.

If you are trying to conceive and your L. gasseri is low alongside low L. crispatus, talk to a reproductive medicine specialist before starting fertility treatment. Some clinics now screen the vaginal microbiome before IVF because dysbiosis can affect outcomes. If you are pregnant and your swab shows low Lactobacillus diversity with high BV-associated bacteria, your obstetric team may want to discuss preterm birth risk monitoring.

An oral probiotic trial of L. gasseri CECT 30648 in 48 healthy women successfully colonized the vagina in 55.9% of recipients over an 18-day intervention and shifted communities toward Lactobacillus-dominated states. Vaginal probiotic products containing L. gasseri have also shown effects on Nugent scores after BV treatment. Other studies of oral Lactobacillus probiotics have shown no detectable effect on vaginal composition, so whether a probiotic will work for you depends on the specific strain, your baseline community, and whether your gut is the route of delivery.

Putting It in Context

L. gasseri is one of several markers researchers use to characterize the vaginal microbiome. It is not a stand-alone diagnostic for any disease. Its real value is as a sentinel of whether your local ecology leans protective or vulnerable. Reading it alongside L. crispatus, L. iners, L. jensenii, and the major BV-associated species gives you a far more complete picture than any single number could.